CAS: 1510712-69-2
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | Glycine,N-[4-[[6-amino-2-(butylamino)-7,8-dihydro-8-oxo-9H-purin-9-yl]methyl]benzoyl] REF: 3D-KKC71269CAS: 1510712-69-2 | Min. 95% | Nachfragen | Di 21 Jan 25 |
 | CL264 REF: TM-T10833CAS: 1510712-69-2 | 97.14% | 85,00 €~1.820,00 € | Mo 27 Jan 25 |
![Glycine,N-[4-[[6-amino-2-(butylamino)-7,8-dihydro-8-oxo-9H-purin-9-yl]methyl]benzoyl]](https://static.cymitquimica.com/products/3D/thumb/KKC71269.jpg)
Glycine,N-[4-[[6-amino-2-(butylamino)-7,8-dihydro-8-oxo-9H-purin-9-yl]methyl]benzoyl]
CAS:1510712-69-2
Please enquire for more information about Glycine,N-[4-[[6-amino-2-(butylamino)-7,8-dihydro-8-oxo-9H-purin-9-yl]methyl]benzoyl] including the price, delivery time and more detailed …
Formel:
C19H23N7O4
Reinheit:
Min. 95%
Molekulargewicht:
413.4 g/mol
Ref: 3D-KKC71269
| 10mg | Nachfragen | ||
| 25mg | Nachfragen | ||
| 50mg | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 21. Januar 2025
CL264
CAS:1510712-69-2
CL264, a selective agonist of TLR7, can be used in studies about innate immune signals.
Formel:
C19H23N7O4
Reinheit:
97.14%
Farbe und Form:
Solid
Molekulargewicht:
413.43
Ref: TM-T10833
| 1mg | 85,00 € | ||
| 5mg | 182,00 € | ||
| 10mg | 313,00 € | ||
| 25mg | 496,00 € | ||
| 50mg | 686,00 € | ||
| 100mg | 911,00 € | ||
| 500mg | 1.820,00 € | ||
| 1mL*10mM (DMSO) | 205,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 27. Januar 2025
